by | Jul 16, 2023 | Publications
Bioorg Med Chem. 2023 Jul 7;91:117408. doi: 10.1016/j.bmc.2023.117408. Online ahead of print. ABSTRACT Infection with the retrovirus human T-cell leukemia virus type 1 (HTLV-1) sometimes causes diseases that are difficult to cure. To find anti-HTLV-1 natural...
by | Jul 16, 2023 | Publications
Braz J Microbiol. 2023 Jul 16. doi: 10.1007/s42770-023-01067-2. Online ahead of print. ABSTRACT INTRODUCTION: The present study had the objective to describe the molecular prevalence and epidemiological aspects of the human T-lymphotropic virus 2 (HTLV-2) infection in...
by | Jul 14, 2023 | Publications
Int J Mol Sci. 2023 Jun 26;24(13):10643. doi: 10.3390/ijms241310643. ABSTRACT Small RNAs (sRNAs) are epigenetic regulators of essential biological processes associated with the development and progression of leukemias, including adult T-cell leukemia/lymphoma (ATLL)...
by | Jul 14, 2023 | Publications
Iran J Microbiol. 2023 Jun;15(3):475-481. doi: 10.18502/ijm.v15i3.12910. ABSTRACT BACKGROUND AND OBJECTIVES: HTLV-1 is responsible for two important diseases, HAM/TSP and ATLL. Approximately 10 to 20 million people are infected with HTLV-1 worldwide. Identifying...
by | Jul 10, 2023 | Publications
Front Microbiol. 2023 Jun 22;14:1217134. doi: 10.3389/fmicb.2023.1217134. eCollection 2023. ABSTRACT INTRODUCTION: Human T-lymphotropic virus 2 (HTLV-2) has been described for more than 30 years as an endemic infection in Brazilian indigenous populations, with its...
by | Jul 10, 2023 | Publications
Front Microbiol. 2023 Jun 22;14:1187697. doi: 10.3389/fmicb.2023.1187697. eCollection 2023. ABSTRACT INTRODUCTION: Understanding of human T-lymphotropic virus (HTLV) remains largely based on epidemiologic and clinical data from endemic areas. Globalization has...
